X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Copay assistance is a lifeline for patients. So why are insurers blocking it?

By Stephen J. Ubl  |    June 29, 2022
In today’s broken insurance system, patients too often pay more for a medicine than what their insurance company pays.   Read More

New poll shows voters sounding the alarm on health insurance companies and PBMs

By Cynthia Hicks  |    June 6, 2022
Many Americans battle with an illness every day, but unfortunately for some, their illness is not the only battle they face. A recent Morning Consult/PhRMA poll of 2,004 registered voters shows that...   Read More

In comments to federal agency, PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for prescription medicines

By Brian Newell  |    May 31, 2022
In comments submitted to the Federal Trade Commission (FTC), PhRMA urged the agency to examine how pharmacy benefit managers (PBMs) leverage their extraordinary power to maximize profits, often in...   Read More

Report finds PBMs are increasingly restricting patient access to medicines

By Brian Newell  |    May 25, 2022
More than 1,150 medicines were excluded from at least one of the three largest PBMs’ standard commercial formularies in 2022, according to a new report from Xcenda. The report is further evidence of...   Read More

ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

By Emilie Signora  |    May 9, 2022
The COVID-19 pandemic has made clear how important a stable health care system is to the American people, both during times of crisis and beyond. Patients deserve sustainable, patient-centered...   Read More

Study finds insurance barriers disproportionately burden patients with chronic illness

By Cynthia Hicks  |    May 4, 2022
A recent Patient Experience Survey found that Americans with serious chronic conditions, including autoimmune diseases, mental health conditions and neurologic conditions were more likely than all...   Read More

5 public opinion polling trends to watch

By Tom Wilbur  |    April 22, 2022
Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize.   Read More

Analysis: States can help patients save nearly $1,000 annually on their medicines

By Reid Porter  |    April 21, 2022
According to a new Ipsos/PhRMA poll, most Americans — 82% — agree that lowering out-of-pocket costs for health care should be a top priority for policymakers. A good place to start in lowering these...   Read More

How standardized plans can improve patients’ access to medicines

By Emilie Signora  |    April 18, 2022
While insurers negotiate steep discounts on medicines, they don’t always share these savings directly with patients. In recent years, insurers have shifted costs for brand medicines to patients by...   Read More

The patient experience: Uncovering the barriers to care for insured Americans

By Cynthia Hicks  |    March 28, 2022
Nearly half of insured Americans who take prescription medicines encounter affordability and access barriers to care, according to the findings of the newest installment of the Patient Experience...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates